Holdings
Orbimed Advisors LLC
As of Jun 30, 2026, Orbimed Advisors LLC reported 107 positions worth US$4.74B. Largest: Edgewise Therapeutics, Inc., Enliven Therapeutics, Inc. and Eli Lilly And Company. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Edgewise Therapeutics, Inc. | 15.5M | US$631M | no change | Jun 30, 2026 |
| Enliven Therapeutics, Inc. | 6.78M | US$344M | −1.18M | Jun 30, 2026 |
| Eli Lilly And Company | 258K | US$309M | +21,100 | Jun 30, 2026 |
| Mbx Biosciences, Inc. | 3.43M | US$189M | −209K | Jun 30, 2026 |
| Sinovac Biotech, Ltd. | 2.72M | US$184M | no change | Jun 30, 2026 |
| Sionna Therapeutics, Inc. | 2.56M | US$112M | −975K | Jun 30, 2026 |
| Corvus Pharmaceuticals, Inc. | 7.17M | US$107M | no change | Jun 30, 2026 |
| Arrivent Biopharma, Inc. | 3.03M | US$105M | no change | Jun 30, 2026 |
| Guardant Health, Inc. | 584K | US$87.6M | +149K | Jun 30, 2026 |
| Argenx Se | 92,880 | US$86.2M | −44,020 | Jun 30, 2026 |